Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

L S Tzouvelekis

Showing results (1-10 of 116) with videos related to

Pageof 12
Sort By:
Current Pharmaceutical Design|December 14, 1999
SHV-type beta-lactamasesL S Tzouvelekis, R A Bonomo
International Journal of Antimicrobial Agents|May 3, 2003
Characterization of Klebsiella pneumoniae clinical strains producing a rare extended-spectrum beta-lactamase (IBC-1)S Vourli, L S Tzouvelekis, E Tzelepi, et al.
Diagnostic Microbiology and Infectious Disease|November 14, 1997
High rates of resistance to piperacillin/tazobactam among Escherichia coli and Klebsiella pneumoniae strains isolated in a Greek hospitalA Tsakris, J Douboyas, L S Tzouvelekis
The Journal of Antimicrobial Chemotherapy|August 1, 1994
In-vitro activity of ampicillin/sulbactam against multiresistant Acinetobacter calcoaceticus var. anitratus clinical isolatesJ Douboyas, L S Tzouvelekis, A Tsakris
The Journal of Antimicrobial Chemotherapy|July 1, 1989
Susceptibility of fifteen Chlamydia trachomatis strains isolated in GreeceA F Mentis, L S Tzouvelekis, L Mavrommati
Microbial Drug Resistance (Larchmont, N.Y.)|January 1, 1995
Prevalent mechanisms of resistance among common enterobacterial isolates in Greek hospitalsN J Legakis, A Maniatis, L S Tzouvelekis
Antimicrobial Agents and Chemotherapy|September 1, 1994
Nucleotide sequence of a plasmid-mediated cephalosporinase gene (blaLAT-1) found in Klebsiella pneumoniaeL S Tzouvelekis, E Tzelepi, A F Mentis
FEMS Microbiology Letters|December 30, 1998
Effect of substitution of Asn for Arg-276 in the cefotaxime-hydrolyzing class A beta-lactamase CTX-M-4M Gazouli, N J Legakis, L S Tzouvelekis
Chemotherapy|July 29, 1998
In vitro activity of loracarbef against TEM extended-spectrum beta-lactamase-producing Escherichia coli strains and its interaction with the enzymesE E Prinarakis, L S Tzouvelekis, N J Legakis
FEMS Microbiology Letters|March 12, 1998
Substitution of Arg-244 by Cys or Ser in SHV-1 and SHV-5 beta-lactamases confers resistance to mechanism-based inhibitors and reduces catalytic efficiency of the enzymesP Giakkoupi, E Tzelepi, N J Legakis, et al.
Pageof 12

Showing results (1-10 of 116) with videos related to

Sort By:
Pageof 12
Current Pharmaceutical Design|December 14, 1999
SHV-type beta-lactamasesL S Tzouvelekis, R A Bonomo
International Journal of Antimicrobial Agents|May 3, 2003
Characterization of Klebsiella pneumoniae clinical strains producing a rare extended-spectrum beta-lactamase (IBC-1)S Vourli, L S Tzouvelekis, E Tzelepi, et al.
Diagnostic Microbiology and Infectious Disease|November 14, 1997
High rates of resistance to piperacillin/tazobactam among Escherichia coli and Klebsiella pneumoniae strains isolated in a Greek hospitalA Tsakris, J Douboyas, L S Tzouvelekis
The Journal of Antimicrobial Chemotherapy|August 1, 1994
In-vitro activity of ampicillin/sulbactam against multiresistant Acinetobacter calcoaceticus var. anitratus clinical isolatesJ Douboyas, L S Tzouvelekis, A Tsakris
The Journal of Antimicrobial Chemotherapy|July 1, 1989
Susceptibility of fifteen Chlamydia trachomatis strains isolated in GreeceA F Mentis, L S Tzouvelekis, L Mavrommati
Microbial Drug Resistance (Larchmont, N.Y.)|January 1, 1995
Prevalent mechanisms of resistance among common enterobacterial isolates in Greek hospitalsN J Legakis, A Maniatis, L S Tzouvelekis
Antimicrobial Agents and Chemotherapy|September 1, 1994
Nucleotide sequence of a plasmid-mediated cephalosporinase gene (blaLAT-1) found in Klebsiella pneumoniaeL S Tzouvelekis, E Tzelepi, A F Mentis
FEMS Microbiology Letters|December 30, 1998
Effect of substitution of Asn for Arg-276 in the cefotaxime-hydrolyzing class A beta-lactamase CTX-M-4M Gazouli, N J Legakis, L S Tzouvelekis
Chemotherapy|July 29, 1998
In vitro activity of loracarbef against TEM extended-spectrum beta-lactamase-producing Escherichia coli strains and its interaction with the enzymesE E Prinarakis, L S Tzouvelekis, N J Legakis
FEMS Microbiology Letters|March 12, 1998
Substitution of Arg-244 by Cys or Ser in SHV-1 and SHV-5 beta-lactamases confers resistance to mechanism-based inhibitors and reduces catalytic efficiency of the enzymesP Giakkoupi, E Tzelepi, N J Legakis, et al.
Pageof 12